Gabelli & Co Investment Advisers’s Clorox CLX Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,000	Closed	-$207K	–	324
2026 Q1	$207K	Hold	2,000	–	–	0.03%	230
2025 Q4	$202K	Hold	2,000	–	–	0.03%	222
2025 Q3	$247K	Hold	2,000	–	–	0.04%	201
2025 Q2	$240K	Hold	2,000	–	–	0.04%	201
2025 Q1	$295K	Hold	2,000	–	–	0.04%	169
2024 Q4	$325K	Buy	+2,000	New	+$327K	0.06%	155
2024 Q3	–	Sell	-2,000	Closed	-$273K	–	231
2024 Q2	$273K	Hold	2,000	–	–	0.05%	169
2024 Q1	$306K	Hold	2,000	–	–	0.05%	150
2023 Q4	$285K	Hold	2,000	–	–	0.05%	152
2023 Q3	$262K	Hold	2,000	–	–	0.04%	158
2023 Q2	$318K	Buy	+2,000	New	+$323K	0.05%	139
2022 Q4	–	Sell	-3,000	Closed	-$385K	–	303
2022 Q3	$385K	Sell	3,000 -500	-14%	-$72.1K	0.05%	226
2022 Q2	$493K	Hold	3,500	–	–	0.06%	217
2022 Q1	$487K	Hold	3,500	–	–	0.06%	225
2021 Q4	$610K	Hold	3,500	–	–	0.08%	193
2021 Q3	$580K	Hold	3,500	–	–	0.07%	192
2021 Q2	$630K	Hold	3,500	–	–	0.07%	172
2021 Q1	$675K	Sell	3,500 -4,000	-53%	-$770K	0.08%	159
2020 Q4	$1.51M	Buy	+7,500	New	+$1.55M	0.24%	84

Other funds holding CLX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Gabelli & Co Investment Advisers's CLX Position: Q2 2026 in Review

Gabelli & Co Investment Advisers sold out of Clorox (CLX) in Q2 2026, closing a stake of 2,000 shares — an estimated $207K sold.

Gabelli & Co Investment Advisers first reported a position in CLX in Q4 2020 and held it in 19 quarters. The position peaked at $1.51M in Q4 2020. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

Gabelli & Co Investment Advisers reported no remaining Clorox position as of Q2 2026 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 2,000 Clorox shares in Q2 2026, an estimated $207K.
Gabelli & Co Investment Advisers first reported a position in Clorox in Q4 2020 and held it in 19 quarters.
Gabelli & Co Investment Advisers's Clorox position peaked at $1.51M in Q4 2020.
1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.